Details of Drug

Details of Drug

 Drug General Information (ID: D1800)
  Drug Name
Glatiramer
  Drug Type Protein/peptide
  Drug Synonymous
Glatiramer|28704-27-0|COP-1|(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid|DTXSID50182865
    Click to Show/Hide
  Therapeutic Class Immunomodulatory Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C23H41N5O11
  InChI InChI=1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6)/t8-;5-;3-;2-/m0000/s1
  InChIKey YLOCGHYTXIINAI-XKUOMLDTSA-N
  Canonical SMILES C[C@@H](C(=O)O)N.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N
  External Link
Pubchem ID 65370

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM043  Additive immunosuppressive effects
  Relation Graph
 Full list of drugs interacting with Glatiramer
      Pharmacodynamic additive effects
   Additive immunosuppressive effects Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1111
 
Natalizumab
 
NA
 
NA
Major    Inter Info   
[1]
References
1 Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.